The role of STAT1 for crosstalk between fibroblasts and colon cancer cells

Pawan Kaler, Benjamin Y. Owusu, Leonard H. Augenlicht, Lidija Klampfer

Research output: Contribution to journalArticle

13 Citations (Scopus)

Abstract

Signaling between tumor cells and the associated stroma has an important impact on cancer initiation and progression. The tumor microenvironment has a paradoxical role in tumor progression and fibroblasts, a major component of the tumor stroma, have been shown to either inhibit or promote cancer development. In this study, we established that normal intestinal fibroblasts activate STAT1 signaling in colon cancer cells and, in contrast to cancer-associated fibroblasts, inhibit growth of tumor cells. Treatment of 18Co fibroblasts with the proinflammatory cytokine TNFa interfered with their ability to trigger STAT1 signaling in cancer cells. Accordingly, intestinal myofibroblasts isolated from patients with ulcerative colitis or Crohn's disease, which are activated and produce high levels of TNFa, failed to stimulate STAT1 signaling in tumor cells, demonstrating that activated myofibroblasts lose the ability to trigger growth-inhibitory STAT1 signaling in tumor cells. Finally, we confirmed that silencing of STAT1 in tumor cells alters the crosstalk between tumor cells and fibroblasts, suggesting STAT1 as a novel link between intestinal inflammation and colon cancer. We demonstrated that normal fibroblasts restrain the growth of carcinoma cells, at least in part, through the induction of STAT1 signaling in cancer cells and showed that changes in the microenvironment, as they occur in inflammatory bowel disease, alter the crosstalk between carcinoma cells and fibroblasts, perturb the homeostasis of intestinal tissue, and thereby contribute to tumor progression.

Original languageEnglish (US)
Article numberArticle 88
JournalFrontiers in Oncology
Volume4 APR
DOIs
StatePublished - 2014

Fingerprint

Colonic Neoplasms
Fibroblasts
Neoplasms
Myofibroblasts
Growth
Intestinal Neoplasms
Carcinoma
Tumor Microenvironment
Ulcerative Colitis
Inflammatory Bowel Diseases
Crohn Disease
Homeostasis
Cytokines
Inflammation

Keywords

  • Colon cancer
  • Fibroblasts
  • Proliferation
  • STAT1
  • Tumor microenvironment

ASJC Scopus subject areas

  • Cancer Research
  • Oncology

Cite this

The role of STAT1 for crosstalk between fibroblasts and colon cancer cells. / Kaler, Pawan; Owusu, Benjamin Y.; Augenlicht, Leonard H.; Klampfer, Lidija.

In: Frontiers in Oncology, Vol. 4 APR, Article 88, 2014.

Research output: Contribution to journalArticle

Kaler, Pawan ; Owusu, Benjamin Y. ; Augenlicht, Leonard H. ; Klampfer, Lidija. / The role of STAT1 for crosstalk between fibroblasts and colon cancer cells. In: Frontiers in Oncology. 2014 ; Vol. 4 APR.
@article{f08729254ab349ebad63adee5f49a908,
title = "The role of STAT1 for crosstalk between fibroblasts and colon cancer cells",
abstract = "Signaling between tumor cells and the associated stroma has an important impact on cancer initiation and progression. The tumor microenvironment has a paradoxical role in tumor progression and fibroblasts, a major component of the tumor stroma, have been shown to either inhibit or promote cancer development. In this study, we established that normal intestinal fibroblasts activate STAT1 signaling in colon cancer cells and, in contrast to cancer-associated fibroblasts, inhibit growth of tumor cells. Treatment of 18Co fibroblasts with the proinflammatory cytokine TNFa interfered with their ability to trigger STAT1 signaling in cancer cells. Accordingly, intestinal myofibroblasts isolated from patients with ulcerative colitis or Crohn's disease, which are activated and produce high levels of TNFa, failed to stimulate STAT1 signaling in tumor cells, demonstrating that activated myofibroblasts lose the ability to trigger growth-inhibitory STAT1 signaling in tumor cells. Finally, we confirmed that silencing of STAT1 in tumor cells alters the crosstalk between tumor cells and fibroblasts, suggesting STAT1 as a novel link between intestinal inflammation and colon cancer. We demonstrated that normal fibroblasts restrain the growth of carcinoma cells, at least in part, through the induction of STAT1 signaling in cancer cells and showed that changes in the microenvironment, as they occur in inflammatory bowel disease, alter the crosstalk between carcinoma cells and fibroblasts, perturb the homeostasis of intestinal tissue, and thereby contribute to tumor progression.",
keywords = "Colon cancer, Fibroblasts, Proliferation, STAT1, Tumor microenvironment",
author = "Pawan Kaler and Owusu, {Benjamin Y.} and Augenlicht, {Leonard H.} and Lidija Klampfer",
year = "2014",
doi = "10.3389/fonc.2014.00088",
language = "English (US)",
volume = "4 APR",
journal = "Frontiers in Oncology",
issn = "2234-943X",
publisher = "Frontiers Media S. A.",

}

TY - JOUR

T1 - The role of STAT1 for crosstalk between fibroblasts and colon cancer cells

AU - Kaler, Pawan

AU - Owusu, Benjamin Y.

AU - Augenlicht, Leonard H.

AU - Klampfer, Lidija

PY - 2014

Y1 - 2014

N2 - Signaling between tumor cells and the associated stroma has an important impact on cancer initiation and progression. The tumor microenvironment has a paradoxical role in tumor progression and fibroblasts, a major component of the tumor stroma, have been shown to either inhibit or promote cancer development. In this study, we established that normal intestinal fibroblasts activate STAT1 signaling in colon cancer cells and, in contrast to cancer-associated fibroblasts, inhibit growth of tumor cells. Treatment of 18Co fibroblasts with the proinflammatory cytokine TNFa interfered with their ability to trigger STAT1 signaling in cancer cells. Accordingly, intestinal myofibroblasts isolated from patients with ulcerative colitis or Crohn's disease, which are activated and produce high levels of TNFa, failed to stimulate STAT1 signaling in tumor cells, demonstrating that activated myofibroblasts lose the ability to trigger growth-inhibitory STAT1 signaling in tumor cells. Finally, we confirmed that silencing of STAT1 in tumor cells alters the crosstalk between tumor cells and fibroblasts, suggesting STAT1 as a novel link between intestinal inflammation and colon cancer. We demonstrated that normal fibroblasts restrain the growth of carcinoma cells, at least in part, through the induction of STAT1 signaling in cancer cells and showed that changes in the microenvironment, as they occur in inflammatory bowel disease, alter the crosstalk between carcinoma cells and fibroblasts, perturb the homeostasis of intestinal tissue, and thereby contribute to tumor progression.

AB - Signaling between tumor cells and the associated stroma has an important impact on cancer initiation and progression. The tumor microenvironment has a paradoxical role in tumor progression and fibroblasts, a major component of the tumor stroma, have been shown to either inhibit or promote cancer development. In this study, we established that normal intestinal fibroblasts activate STAT1 signaling in colon cancer cells and, in contrast to cancer-associated fibroblasts, inhibit growth of tumor cells. Treatment of 18Co fibroblasts with the proinflammatory cytokine TNFa interfered with their ability to trigger STAT1 signaling in cancer cells. Accordingly, intestinal myofibroblasts isolated from patients with ulcerative colitis or Crohn's disease, which are activated and produce high levels of TNFa, failed to stimulate STAT1 signaling in tumor cells, demonstrating that activated myofibroblasts lose the ability to trigger growth-inhibitory STAT1 signaling in tumor cells. Finally, we confirmed that silencing of STAT1 in tumor cells alters the crosstalk between tumor cells and fibroblasts, suggesting STAT1 as a novel link between intestinal inflammation and colon cancer. We demonstrated that normal fibroblasts restrain the growth of carcinoma cells, at least in part, through the induction of STAT1 signaling in cancer cells and showed that changes in the microenvironment, as they occur in inflammatory bowel disease, alter the crosstalk between carcinoma cells and fibroblasts, perturb the homeostasis of intestinal tissue, and thereby contribute to tumor progression.

KW - Colon cancer

KW - Fibroblasts

KW - Proliferation

KW - STAT1

KW - Tumor microenvironment

UR - http://www.scopus.com/inward/record.url?scp=84901036225&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84901036225&partnerID=8YFLogxK

U2 - 10.3389/fonc.2014.00088

DO - 10.3389/fonc.2014.00088

M3 - Article

VL - 4 APR

JO - Frontiers in Oncology

JF - Frontiers in Oncology

SN - 2234-943X

M1 - Article 88

ER -